Enavogliflozin: all 33 studies that test it

Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes MellitusNot yet recruitingNCT07619833Phase 3
• Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThyRecruitingNCT07240844Phase 4
• Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in ObesityRecruitingNCT06782139Phase 4
• Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy AdultsNot yet recruitingNCT06644404Phase 1
• A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus PatientsRecruitingNCT06642623Phase 4
• Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment PatientsNot yet recruitingNCT06606093Phase 3
• ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathyRecruitingNCT06580717Phase 4
• Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter AblationRecruitingNCT06528262Phase 4
• Enavogliflozin vs. Pioglitazone on Glucose and AtherosclerosisRecruitingNCT06399835Phase 4
• Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes MellitusNot yet recruitingNCT06141980Phase 3
• To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult VolunteersRecruitingNCT05797922Phase 1
• To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic FunctionRecruitingNCT05747664Phase 1
• ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve ReplacementRecruitingNCT05672836Phase 4
• A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes MellitusRecruitingNCT05466643Phase 3
• Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy AdultsCompletedNCT07213310Phase 1
• Enavogliflozin Outcome Trial in Functional Tricuspid RegurgitationActive, not recruitingNCT06027307Phase 3
• To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose CombinationStatus unknownNCT05737771Phase 1
• The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminActive, not recruitingNCT05505994Phase 3
• Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male AdultsStatus unknownNCT05500898Phase 1
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and CCompletedNCT05465668Phase 1
• Pharmacokinetics and Safety Following Administration of DWP16001CompletedNCT05414591Phase 1
• Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on MetforminCompletedNCT05376969Phase 3
• Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.CompletedNCT05376930Phase 3
• The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy AdultsStatus unknownNCT05321732Phase 1
• Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various EthnicitiesStatus unknownNCT05207176Phase 1
• A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy VolunteersCompletedNCT05192395Phase 1
• The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes MellitusCompletedNCT04654390Phase 3
• The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.CompletedNCT04632862Phase 3
• Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male AdultsStatus unknownNCT04343547Phase 1
• Type 2 Diabetes Patients With Renal ImpairmentStatus unknownNCT04221399Phase 1
• Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)CompletedNCT04064073Phase 1
• Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes MellitusStatus unknownNCT04014023Phase 2
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male VolunteersCompletedNCT03364985Phase 1

← Enavogliflozin overview